Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease
Columbia University Irving Medical Center · Helios Hospital Siegburg · +2 more institutions
Abstract
BACKGROUND: The morbidity and mortality of surgical aortic valve replacement are increased in elderly patients with multiple high-risk comorbid conditions. Therefore, a prospective, single-center, nonrandomized study was performed in high-risk patients with aortic valve disease to evaluate the feasibility and safety of percutaneous implantation of a novel self-expanding aortic valve bioprosthesis (CoreValve). METHODS AND RESULTS: Symptomatic high-risk patients with an aortic valve area
Citation impact
- FWCI
- 37.66
- Percentile
- 100%
- References
- 21
Authors
12- EGEberhard GrubeCorresponding
Columbia University Irving Medical Center, Helios Hospital Siegburg, Clinique Pasteur, Cardiovascular Research Foundation
- JCJean Claude Laborde
Columbia University Irving Medical Center, Helios Hospital Siegburg, Clinique Pasteur, Cardiovascular Research Foundation
- UGUlrich Gerckens
Columbia University Irving Medical Center, Helios Hospital Siegburg, Clinique Pasteur, Cardiovascular Research Foundation
- TFThomas Felderhoff
Columbia University Irving Medical Center, Helios Hospital Siegburg, Clinique Pasteur, Cardiovascular Research Foundation
- BSBarthel Sauren
Columbia University Irving Medical Center, Helios Hospital Siegburg, Clinique Pasteur, Cardiovascular Research Foundation
Topics & keywords
- Medicine
- Cardiology
- Stenosis
- Internal medicine
- Percutaneous
- Regurgitation (circulation)
- Surgery
- Aortic valve
- Good health and well-being